Luminopia's amblyopia treatment now includes patients aged 8 to 12, expanding its previous FDA approval for ages 4 to 7. The ...

Alkermes has a huge opportunity to expand its label to include pediatric patients with Schizophrenia and bipolar I disorder.

Recent advances in diabetes technology have transformed the clinical management of type 1 diabetes in children and adolescents. The integration of ...

Polycystic ovarian syndrome (PCOS) is a complex disorder of metabolism, endocrine function, and the reproductive system that affects an estimated 1 in 10 ...